Cargando…
Oral immunization with LacVax® OmpA induces protective immune response against Shigella flexneri 2a ATCC 12022 in a murine model
Shigellosis is an acute invasive disease of the lower intestine, which afflicts millions of people worldwide with an estimated one million fatalities per annum. Despite of extensive research during the last two decades, a vaccine against multi-drug resistant Shigella is not yet available in the mark...
Autores principales: | Yagnik, Bhrugu, Sharma, Drashya, Padh, Harish, Desai, Priti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115592/ https://www.ncbi.nlm.nih.gov/pubmed/31047673 http://dx.doi.org/10.1016/j.vaccine.2019.04.053 |
Ejemplares similares
-
EpiMix Based Novel Vaccine Candidate for Shigella: Evidence of Prophylactic Immunity in Balb/c Mice
por: Padh, Harish, et al.
Publicado: (2021) -
Genome Assembly of Shigella flexneri ATCC 12022, a Quality Control Reference Strain
por: Daligault, H. E., et al.
Publicado: (2014) -
Outer Membrane Protein A (OmpA) of Shigella flexneri 2a, Induces Protective Immune Response in a Mouse Model
por: Pore, Debasis, et al.
Publicado: (2011) -
Outer Membrane Protein A (OmpA): A New Player in Shigella flexneri Protrusion Formation and Inter-Cellular Spreading
por: Ambrosi, Cecilia, et al.
Publicado: (2012) -
The Shigella flexneri OmpA amino acid residues (188)EVQ(190) are essential for the interaction with the virulence factor PhoN2
por: Scribano, Daniela, et al.
Publicado: (2016)